Search

Your search keyword '"Roden, DM"' showing total 905 results

Search Constraints

Start Over You searched for: Author "Roden, DM" Remove constraint Author: "Roden, DM"
905 results on '"Roden, DM"'

Search Results

1. New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine

2. A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin

3. Genetic Variants in Transcription Factors Are Associated With the Pharmacokinetics and Pharmacodynamics of Metformin

4. Characterization of Statin Dose Response in Electronic Medical Records

5. Erratum: Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin (Clinical Pharmacology and Therapeutics (2014) 96:3 (370-379) DOI:10.1038/clpt.2014.109)

6. The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin

7. Next-Generation Phenotyping: Introducing PhecodeX for Enhanced Discovery Research in Medical Phenomics

8. A common polymorphism associated with antibiotic-induced cardiac arrhythmia.

9. Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension

10. A saturated map of common genetic variants associated with human height

11. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems

12. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

13. Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome

14. An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition

17. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

18. Genetic determinants of risk in pulmonary arterial hypertension: international case-control studies and meta-analysis

19. Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes

20. PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity

21. Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium

22. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study

24. Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network

27. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation

28. Defining the role of common variation in the genomic and biological architecture of adult human height.

29. Characterization of statin dose response in electronic medical records.

30. Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization

31. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society

32. American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association and the Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

33. American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

34. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death

35. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome

36. Cardiac potassium channel dysfunction in sudden infant death syndrome

38. KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome

40. Clinically Actionable Genotypes Among 10,000 Patients With Preemptive Pharmacogenomic Testing.

42. Systems biology and cardiac arrhythmias.

43. A KCNJ8 mutation associated with early repolarization and atrial fibrillation.

48. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Catalog

Books, media, physical & digital resources